Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Net Income (Common)
Aslan Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Net Income (Common)
-$11.6m
|
CAGR 3-Years
26%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
-11.6m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Net Income (Common) amounts to -11.6m USD.
What is Aslan Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
15%
Over the last year, the Net Income (Common) growth was 59%. The average annual Net Income (Common) growth rates for Aslan Pharmaceuticals Ltd have been 26% over the past three years , 15% over the past five years .